Brooklyn Health

Brooklyn Health is a US-based company focused on advancing mental health measurement through innovative digital solutions, particularly its electronic Clinical Outcome Assessment tool, Willis, aimed at improving clinical trial efficacy. Founded in 2023 and headquartered in Brooklyn, US, Brooklyn Health specializes in developing solutions for mental health assessments. The company has secured funding through a SEED round, raising a total of USD 6. 5 mn, led by HealthX Ventures and supported by several notable investors.

The most recent deal was completed on May 27, 2025, marking the company's first major financing effort in its operational history. Brooklyn Health specializes in the development of innovative solutions aimed at modernizing mental health measurement, particularly through its flagship product, Willis, an electronic Clinical Outcome Assessment (eCOA) tool. This solution is designed to enhance the efficiency and accuracy of mental health assessments during clinical trials, thereby addressing significant challenges faced by researchers and healthcare providers in tracking patient outcomes. The primary end users of Brooklyn Health's offerings include pharmaceutical companies, clinical research organizations, and healthcare institutions engaged in mental health research.

By providing a streamlined approach to data collection and analysis, Brooklyn Health aims to facilitate improved decision-making in clinical settings. The company's products are marketed primarily in North America and Europe, targeting regions with a robust landscape for clinical trials and mental health research. Brooklyn Health generates revenue through a subscription-based model for its eCOA solution, Willis, catering to various stakeholders in the clinical trials ecosystem. Clients typically include pharmaceutical companies and clinical research organizations that require reliable tools for measuring mental health outcomes.

Transactions are structured around annual or multi-year subscriptions, allowing clients to access the platform for data collection and analysis. Pricing plans are designed to accommodate the varying needs of different organizations, ensuring scalability and flexibility in their use of the platform. The company’s revenue model is built on delivering value through enhanced data accuracy and operational efficiencies, positioning Brooklyn Health as a critical partner in the clinical research sector. In May 2025, Brooklyn Health raised USD 6.

5 mn in SEED funding led by HealthX Ventures to support the launch of its electronic clinical outcome assessment solution, Willis. The company plans to enhance its product offerings and expand into new markets in North America and Europe by the end of 2025, focusing on regions with increasing demand for mental health research tools. The recent funding will play a crucial role in these initiatives, enabling Brooklyn Health to solidify its presence in the clinical trials ecosystem.